Press Releases

For press releases issued prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Date Title  
05/27/15

Once-Daily, Dual Mechanism Antibiotic Possesses Profile to Play Key Role in Global Fight Against Antimicrobial Resistance

05/20/15

Findings Support Potential for First Once-Daily Nebulized LAMA in COPD; Initiation of Phase 3 Registrational Trials Planned for 2015

05/18/15

Velusetrag Improved Gastric Emptying Time Across All Doses vs. Placebo; Velusetrag Produced a Clinically Meaningful Improvement in Gastric Emptying Time in Both Diabetic and Idiopathic Gastroparetic Patients

05/07/15

VIBATIV(R) Commercial Activities Gaining Momentum; TD-4208 Phase 3 Program to Commence Second Half 2015; New Product Candidates Advancing Towards the Clinic; Lowering Operating Loss Guidance for 2015

05/04/15
GEORGE TOWN, GRAND CAYMAN -- ( Marketwired ) -- 05/04/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase an aggregate of 7,900 of the Company's ordinary shares were granted to four new non-executive officer
04/30/15
GEORGE TOWN, GRAND CAYMAN -- ( Marketwired ) -- 04/30/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that Rick E Winningham, Chairman and Chief Executive Officer, is scheduled to present at the Bank of America Merrill Lynch 2015 Health Care
04/30/15
GEORGE TOWN, GRAND CAYMAN -- ( Marketwired ) -- 04/30/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the period ended March 31, 2015 after market close on Thursday, May 7, 2015 .
04/24/15

Data Presentations at 2015 ECCMID Conference Highlight Key Findings in Light of the Growing Global Threat of Antibiotic Resistance

04/16/15

Poster Presentations Provide Further Support for Role of VIBATIV(R) in Fight Against Antibiotic Resistance

04/07/15
GEORGE TOWN, GRAND CAYMAN -- ( Marketwired ) -- 04/07/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer, is scheduled to present at the 2015 Needham Healthcare Conference on Tuesday, April 14, 2015 , at 8:00 a.m. EDT .